# US 2026/0144277 A1 · Microbial compositions for fowl health and performance

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0144277 A1
- Document ID: US20260144277A1
- Status: Published application
- Kind: A1
- Application number: 19/252,237
- Filed: 2025-06-27
- Published: 2026-05-28
- Earliest claimed: 2017-10-18
- Assignees: Native Microbials, Inc.
- Applicants: Native Microbials, Inc.
- Inventors: Mallory EMBREE; Grant GOGUL; Cameron MARTINO; Norman PITT
- Web page: https://patentgrep.com/patent/US20260144277A1

## CPC

- A23K 50/75: for poultry
- A23K 10/10: obtained by microbiological or biochemical processes (using chemicals or microorganisms for ensilaging of green fodder A23K30/15)
- A23K 10/16: Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions (A23K10/12 takes precedence)
- A23K 10/18: of live microorganisms
- A23K 50/70: for birds
- A61K 35/741: Probiotics (probiotic yeast, e.g. saccharomyces A61K36/06)
- C12N 1/14: Fungi (culture of mushrooms A01G18/00; as new plants A01H15/00); Culture media therefor
- C12N 1/20: Bacteria; Culture media therefor
- C12N 1/205: Bacterial isolates
- A23V 2400/11: Lactobacillus
- A23K: FODDER
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A23V: INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION

## Abstract

The disclosure relates to isolated microorganisms—including novel strains of the microorganisms—microbial ensembles, and compositions comprising the same. Furthermore, the disclosure teaches methods of utilizing the described microorganisms, microbial ensembles, and compositions comprising the same, in methods for modulating the production of poultry, disease resistance, and egg yield. In particular aspects, the disclosure provides methods of increasing feed efficiency, and methods of preventing colonization of pathogenic microbes.

## Claims

### Claim at position 1

1-40. (canceled)

### Claim 41

A composition comprising:
(a) a purified microbial population that comprises:
(i) a bacterium with a 16S nucleic acid sequence that shares at least 97% sequence identity with SEQ ID NO: 386, and/or
(ii) a bacterium with a 16S nucleic acid sequence that shares at least 97% sequence identity with SEQ ID NO: 387, and
(b) a carrier suitable for fowl administration.

### Claim 42 (depends on 41)

The composition of claim 41, wherein the purified microbial population comprises: a bacterium with a 16S nucleic acid sequence sharing at least 98% sequence identity with SEQ ID NO: 386 and/or a bacterium with a 16S nucleic acid sequence sharing at least 98% sequence identity with SEQ ID NO: 387.

### Claim 43 (depends on 41)

The composition of claim 41, wherein the purified microbial population comprises: a bacterium with a 16S nucleic acid sequence sharing at least 99% sequence identity with SEQ ID NO: 386 and/or a bacterium with a 16S nucleic acid sequence sharing at least 99% sequence identity with SEQ ID NO: 387.

### Claim 44 (depends on 41)

The composition of claim 41, wherein the purified microbial population comprises: a bacterium with a 16S nucleic acid sequence of SEQ ID NO: 386 and/or a bacterium with a 16S nucleic acid sequence of SEQ ID NO: 387.

### Claim 45 (depends on 41)

The composition of claim 41, wherein the purified microbial population comprises a bacterium with a 16S nucleic acid sequence sharing at least 97% sequence identity with SEQ ID NO: 387.

### Claim 46 (depends on 41)

The composition of claim 41, wherein the purified microbial population comprises a bacterium with a 16S nucleic acid sequence sharing at least 98% sequence identity with SEQ ID NO: 387.

### Claim 47 (depends on 41)

The composition of claim 41, wherein the purified microbial population comprises a bacterium with a 16S nucleic acid sequence sharing at least 99% sequence identity with SEQ ID NO: 387.

### Claim 48 (depends on 41)

The composition of claim 41, wherein the purified microbial population comprises a bacterium with a 16S nucleic acid sequence of SEQ ID NO: 387.

### Claim 49 (depends on 41)

The composition of claim 41, wherein the purified microbial population comprises a bacterium as deposited as NRRL B-67691.

### Claim 50 (depends on 41)

The composition of claim 41, wherein the bacterium has a maximal information coefficient (MIC) score of at least 0.1.

### Claim 51 (depends on 41)

The composition of claim 41, wherein the purified microbial population further comprises one or more bacteria with a 16S nucleic acid sequence sharing at least 97% sequence identity with a nucleic acid sequence selected from the group consisting of SEQ ID NOs: 1-50 and 59-385; and/or one or more fungi with an internal transcribed spacer (ITS) nucleic acid sequence that shares at least 97% sequence identity with a nucleic acid sequence selected from the group consisting of SEQ ID NOs: 51-58.

### Claim 52 (depends on 41)

The composition of claim 41, wherein the purified microbial population further comprises one or more bacteria with a 16S nucleic acid sequence sharing at least 98% sequence identity with a nucleic acid sequence selected from the group consisting of: SEQ ID NOs: 1-50 and 59-385; and/or one or more fungi with an ITS nucleic acid sequence that shares at least 98% sequence identity with a nucleic acid sequence selected from the group consisting of: SEQ ID NOs: 51-58.

### Claim 53 (depends on 41)

The composition of claim 41, wherein the purified microbial population further comprises one or more bacteria with a 16S nucleic acid sequence sharing at least 99% sequence identity with a nucleic acid sequence selected from the group consisting of: SEQ ID NOs: 1-50 and 59-385; and/or one or more fungi with an ITS nucleic acid sequence that shares at least 99% sequence identity with a nucleic acid sequence selected from the group consisting of: SEQ ID NOs: 51-58.

### Claim 54 (depends on 41)

The composition of claim 41, wherein the purified microbial population further comprises one or more bacteria with a 16S nucleic acid sequence selected from the group consisting of: SEQ ID NOs: 1-50 and 59-385; and/or one or more fungi with an ITS nucleic acid sequence selected from the group consisting of: SEQ ID NOs: 51-58.

### Claim 55 (depends on 41)

The composition of claim 41, wherein the purified microbial population further comprises one or more bacteria with a 16S nucleic acid sequence sharing at least 97% sequence identity with a nucleic acid sequence selected from the group consisting of: SEQ ID NO: 3, SEQ ID NO: 13, SEQ ID NO: 369, SEQ ID NO: 370, and SEQ ID NO: 374.

### Claim 56 (depends on 41)

The composition of claim 41, wherein the purified microbial population comprises one or more bacteria with a 16S nucleic acid sequence sharing at least 98% sequence identity with a nucleic acid sequence selected from the group consisting of: SEQ ID NO: 3, SEQ ID NO: 13, SEQ ID NO: 369, SEQ ID NO: 370, and SEQ ID NO: 374.

### Claim 57 (depends on 41)

The composition of claim 41, wherein the purified microbial population further comprises one or more bacteria with a 16S nucleic acid sequence sharing at least 99% sequence identity with a nucleic acid sequence selected from the group consisting of: SEQ ID NO:3, SEQ ID NO: 13, SEQ ID NO: 369, SEQ ID NO: 370, and SEQ ID NO: 374.

### Claim 58 (depends on 41)

The composition of claim 41, wherein the purified microbial population further comprises one or more bacteria with a 16S nucleic acid sequence selected from the group consisting of: SEQ ID NO:3, SEQ ID NO: 13, SEQ ID NO: 369, SEQ ID NO: 370, and SEQ ID NO: 374.

### Claim 59 (depends on 41)

The composition of claim 41, wherein the composition is formulated as an encapsulation, tablet, capsule, pill, feed additive, food ingredient, food preparation, food supplement, water additive, water-mixed additive, heat-stabilized additive, moisture-stabilized additive, pre-pelleted feed additive, pelleted feed additive, post-pelleting-applied feed additive, consumable solution, consumable spray additive, consumable solid, consumable gel, injection, suppository, drench, bolus, or combination thereof.

### Claim 60 (depends on 41)

The composition of claim 41, wherein the purified microbial population is encapsulated.

### Claim 61 (depends on 41)

The composition of claim 41, wherein the purified microbial population is sporulated.

### Claim 62 (depends on 41)

The composition of claim 41, wherein the carrier is calcium carbonate.

### Claim 63 (depends on 41)

The composition of claim 41, wherein the purified microbial population is lyophilized.

### Claim 64 (depends on 41)

The composition of claim 41, wherein the composition is formulated as a pelleted feed additive.

### Claim 65 (depends on 41)

The composition of claim 41, wherein the purified microbial population comprises at least 102 cells.

### Claim 66 (depends on 41)

The composition of claim 41, wherein the purified microbial population is present in the composition in an amount effective to improve one or more desirable traits in a fowl as compared to a fowl not having been administered the composition.

### Claim 67 (depends on 41)

The composition of claim 41, wherein the one or more desirable traits is an improvement in the innate immune response, an improvement in incidence of normal gastrointestinal morphology, an improvement in growth rate, an improvement in total body mass, an improvement in feed conversion ratio, an improvement in pathogen exclusion, an improvement in competitive exclusion against pathogens, a reduction in mortality, a reduction in flock variability, an improvement in antimicrobial production, an improvement in stimulating the production of B cells, an improvement in stimulating the production of lymphocytes, an improvement in length of villi, and/or an improvement in expression of inflammatory cytokines.
